Biomedical technology

Yee Hop Holdings' (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva

Retrieved on: 
Montag, Mai 6, 2024
Yee, Hydrogen, Cosmetics, Death, Innovation, Partnership, Water, Life, Invention, Spore, Virus, Environment, APEL, Hydrogen sulfide, Inhalation, Skin, Exhibition, Sustainability, Disinfectant, Smell, Attention, Gold, SGS, Pharmacy, Pet, Safety, Certification, Health, Bacteria, Research, Transport, Carbon, HKUST, Food industry, Human, Translation, Government, Drainage, Division, HKSAR, Sale, Biomedical technology, Biological engineering, Bed, Science park, Hong Kong Technology Venture, Injury, Convention center, HKSTP, Vacuum, New Territories, Fatality, QPP, Translational research, Growth, World's fair, Sewage treatment

APEL performed excellently at the 49th International Exhibition of Inventions Geneva, with three scientific research entries respectively winning two gold and one bronze medals, achieving a 100% success rate.

Key Points: 
  • APEL performed excellently at the 49th International Exhibition of Inventions Geneva, with three scientific research entries respectively winning two gold and one bronze medals, achieving a 100% success rate.
  • This exhibition is one of the largest international exhibitions of inventions, providing inventors and researchers with a unique opportunity to showcase research results and new products.
  • The 49th International Exhibition of Inventions Geneva was held in April in Geneva, Switzerland, featuring over 1,000 inventions from 38 countries and regions.
  • Today, we are delighted to receive recognition from international research institutions and achieve remarkable results at the International Exhibition of Inventions Geneva.

APEL Biomedical Technology Innovation and Translational Commercial Laboratory Officially Opens

Retrieved on: 
Mittwoch, März 13, 2024
Yee, New Territories, Nutrition, Health, Technology transfer, Quality of life, HKSAR, Hygiene, QPP, Corporation, Certification, Environment, Innovation, Biotechnology, Partnership, Biomedical technology, Biological engineering, Translational research, Silk, Knowledge, Research, SGS, Lifestar, Translation, Science park, Sustainability, Pet, Government, Growth, Greater, Perception, PET, HKSTP, APEL, Life, Hong Kong Science Park, Toxicology, Division, Medical imaging

Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.

Key Points: 
  • Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.
  • We have attracted numerous biomedical innovation and technology enterprises, covering areas such as pharmaceuticals, medical devices, diagnostics, and traditional Chinese medicine.
  • Today, we are delighted to have officially established our presence in Hong Kong Science Park with the opening of the Biomedical Technology Innovation and Translational Commercial Laboratory.
  • The pet industry ecosystem is vibrant, and today, during the inauguration ceremony of the APEL Biomedical Technology Innovation and Translational Commercial Laboratory, APEL also organized a panel discussion on the future opportunities and transformations in the pet industry.

The Inner Circle acknowledges Jennifer A. Vazquez as a Pinnacle Lifetime Member

Retrieved on: 
Donnerstag, April 4, 2024
Kentucky Association, Biomedicine, Biomedical engineering, University, Biomedical technology, Growth, Projection, Central Florida, Learning, Knowledge, USB On-The-Go, AAMI, Biomedical equipment technician, DeVry University, Health technology, Health, Inner circle

CINCINNATI, April 4, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jennifer A. Vazquez is acknowledged as a Pinnacle Lifetime Member for her contributions in Medical Technology.

Key Points: 
  • CINCINNATI, April 4, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jennifer A. Vazquez is acknowledged as a Pinnacle Lifetime Member for her contributions in Medical Technology.
  • Jennifer A. Vazquez, a dynamic professional in the field of medical technology, has garnered recognition for her exceptional contributions and achievements in biomedical engineering.
  • With an impressive educational background and a commitment to excellence, Jennifer has established herself as a rising star in the industry.
  • Jennifer A. Vazquez attributes her success to the guidance and mentorship she has received from individuals such as Mr. Edward Reyes and Mr. Enrique Vazquez.

Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner

Retrieved on: 
Donnerstag, Januar 4, 2024
Other Manufacturing, Surgery, Medical Devices, Engineering, Health Technology, Manufacturing, Biotechnology, Other Health, Health, Acclarent, Biomedical technology, Stanford University, Partner, Student, J&J, Mechanical engineering, MIT, American Institute, MBA, MD, Education, Columbia University, Invention, National academy, Patent, Biomedicine, Prostate, Biological engineering, Medtronic, Investment, Patient, Mechanical, Curriculum, Sofinnova, Medical device

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign , has joined Sofinnova as an advisory Venture Partner.

Key Points: 
  • Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign , has joined Sofinnova as an advisory Venture Partner.
  • He is the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.
  • Dr. Makower was a longtime partner in NEA’s healthcare practice, advising the healthcare team and medtech/healthtech investing practice.
  • Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, said: “We are incredibly fortunate to have Josh on board.

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

Retrieved on: 
Donnerstag, Dezember 28, 2023
Biomedical technology, Partnership, Burn, CMC, Bromelain (pharmacology), GMP, Burns, MTEC, Pharmaceutical industry

The $14.4 million project budget will advance the development and production of a new, temperature-stable formulation of NexoBrid, positioning it as the first-line non-surgical solution for treating severe burn injuries in pre-hospital settings.

Key Points: 
  • The $14.4 million project budget will advance the development and production of a new, temperature-stable formulation of NexoBrid, positioning it as the first-line non-surgical solution for treating severe burn injuries in pre-hospital settings.
  • "We are delighted to further solidify our partnership with the U.S. Department of Defense.
  • The additional funding will enhance our CMC activities, expedite preclinical development, and facilitate the establishment of a GMP compliant aseptic production line for the temperature-stable formulation of NexoBrid," announced Ofer Gonen, Chief Executive Officer of MediWound.
  • In alignment with this mission, it's vital to have field solutions for severe burn treatments that are both easy-to-use and effective.

Spectral AI Announces 2023 Third Quarter Financial Results

Retrieved on: 
Montag, November 13, 2023
EBITDA, Classification, Research, Research and development, D, Pediatrics, MDAI, UKCA, Royal college, Spectral, History, Patient, Government, Burn, CE marking, Alpha (finance), FDA, Artificial intelligence, Wound healing, Podiatry, CE, Adjustment, Trial of the century, Development, Partnership, London Stock Exchange, 3D, AI, Biomedical technology, Certification, MTEC, Unitary state, DFU, Medical device, Nursing, Cryptocurrency, Pharmaceutical industry, Management

DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended September 30, 2023 (“Q3 2023”).

Key Points: 
  • DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended September 30, 2023 (“Q3 2023”).
  • As previously announced, we also expect 2024 revenue growth of approximately 60% from anticipated 2023 levels.”
    All comparisons are to the third quarter ended September 30, 2022 (“Q3 2022”) unless otherwise stated.
  • As of September 30, 2023, cash and cash equivalents totaled $7.3 million and the Company had no long-term debt.
  • The Company will host a conference call on Tuesday, November 14, 2023 at 9:00 am Eastern Time to discuss the results.

University of Wisconsin–Madison and GE HealthCare Broaden Shared Commitment to Healthcare Innovation

Retrieved on: 
Freitag, November 17, 2023
Biotechnology, Health, Biometrics, Other Health, Radiology, Pharmaceutical, Surgery, Medical Devices, General Health, Hospitals, Science, Clinical Trials, Nursing, Medical Supplies, Prostate, Research, Chair, Liver, Liver disease, Cardiovascular disease, Particle, Patient, Nuclear medicine, Algorithm, Neurology, Artificial intelligence, Innovation Hub, Physics, Molecular imaging, Standard of care, University, MD, University of Wisconsin–Madison, Diagnosis, Deep learning, Public health, MRI, AI, Particle therapy, Physician, Biomedical technology, Medical physics, GE HealthCare, Medical imaging

The collaboration is aimed at shaping the future of medical imaging, to improve the standard of care and patient outcomes.

Key Points: 
  • The collaboration is aimed at shaping the future of medical imaging, to improve the standard of care and patient outcomes.
  • The decades-long history between GE HealthCare and UW–Madison has an established track record of combining innovative resources to transform patient care.
  • GE HealthCare and UW-Madison have also partnered to create standardized CT protocols for GE HealthCare systems that have been distributed to more than 4,000 sites globally.
  • GE HealthCare and UW-Madison have built a vital collaborative research and technology relationship , generating substantial health innovations including more than 100 patents.

IMG Saxony-Anhalt: excellent medtech research cluster and innovative companies

Retrieved on: 
Donnerstag, Oktober 19, 2023
Science, Applied science, Health, Anhalt University of Applied Sciences, Port, Research, Virus, Calibration, Software, Elbe, Medicine, Transport, Student, Bacteria, Biomedical technology, Cancer, Excellence, Robotics, Medical imaging, Nursing

MAGDEBURG, Germany, Oct. 19, 2023 /PRNewswire/ -- On October 19, the branch will exhibit for the first time at the Germany-wide Innovation Forum held by Technology Mountains e.V. in Tuttlingen, Baden-Württemberg. Under the motto "Taking health to a new level", the primary focus will be on sustainability, robotics, and IT applications – and the firms in Saxony-Anhalt have extensive expertise in the latter.

Key Points: 
  • Here, they benefit from an extensive research and science landscape and networking in clusters.
  • The close interaction between business and academia gives rise to innovations across the entire bandwidth of medtech applications.
  • Returning to the Port of Science, recently named a "Center of Excellence Saxony-Anhalt", the medtech start-up scene is thriving.
  • In our latest press kit , we delve into the world of medical technology, its innovative companies, and the movers and shakers of the medicine of tomorrow.

IMG Saxony-Anhalt: excellent medtech research cluster and innovative companies

Retrieved on: 
Donnerstag, Oktober 19, 2023
Science, Applied science, Health, Anhalt University of Applied Sciences, Port, Research, Virus, Calibration, Software, Elbe, Medicine, Transport, Student, Bacteria, Biomedical technology, Cancer, Excellence, Robotics, Medical imaging, Nursing

MAGDEBURG, Germany, Oct. 19, 2023 /PRNewswire/ -- On October 19, the branch will exhibit for the first time at the Germany-wide Innovation Forum held by Technology Mountains e.V. in Tuttlingen, Baden-Württemberg. Under the motto "Taking health to a new level", the primary focus will be on sustainability, robotics, and IT applications – and the firms in Saxony-Anhalt have extensive expertise in the latter.

Key Points: 
  • Here, they benefit from an extensive research and science landscape and networking in clusters.
  • The close interaction between business and academia gives rise to innovations across the entire bandwidth of medtech applications.
  • Returning to the Port of Science, recently named a "Center of Excellence Saxony-Anhalt", the medtech start-up scene is thriving.
  • In our latest press kit , we delve into the world of medical technology, its innovative companies, and the movers and shakers of the medicine of tomorrow.

Food Allergy Science Initiative (FASI) Appoints New Chief Executive Officer

Retrieved on: 
Dienstag, Oktober 17, 2023
Science, Biotechnology, Research, General Health, Health, Food, Beverage, Retail, Other Health, Centre for Strategic Research and Analysis, MD, Biomedical technology, Therapy, Doctor of Philosophy, Growth, Hope, Biology, Publication, Patient, Management, Pharmaceutical industry

Food Allergy Science Initiative (FASI), a leading food allergy science nonprofit, is pleased to announce the promotion of Dr. Carlos Bosques, PhD to Chief Executive Officer of FASI effective today.

Key Points: 
  • Food Allergy Science Initiative (FASI), a leading food allergy science nonprofit, is pleased to announce the promotion of Dr. Carlos Bosques, PhD to Chief Executive Officer of FASI effective today.
  • Dr. Bosques joined FASI in 2022 as Senior Vice President of Research and quickly became an integral part of the organization's leadership structure.
  • Carlos has already proven himself as a leader in FASI,” said Christine Olsen, MD, Executive Chair, FASI.
  • Since 2016, FASI has invested $37+ million in breakthrough food allergy science in collaboration with a network of 100+ scientists.